Chetan Vakkalagadda, Briana Lee, Jacob Alex, Shauna Rakshe, Jessica Minnier, Jeremy Paul Cetnar. "Utilizing TP53 mutation status and initial disease burden at presentation to risk-stratify patients with advanced EGFR-mutated NSCLC treated with osimertinib.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e20663